The SITC Cancer Immunotherapy Guidelines – Renal Cell Carcinoma Webinar, held on January 7, 2020, is available for continuing education credits. 

Continuing Education Credit Information
Continuing Education Credits are available for physicians, nurses and pharmacists. To view full accreditation information, click here. 

Request Credit

1. Click the Register Now button.
2. You will be prompted to log in or create a free account.
3. Click the Request Credit button.
4. On the Manage Your Credit screen, follow the instructions to select the Credit Reporting Organization you wish to claim credit for. (Note: For pharmacist completers, enter your NABP# (required).) Then click Continue.
5. Complete the evaluation. Then click Submit.
6. On the Confirm All Information screen, verify your Credit Reporting Organization and click Process Credit.
7. On the Education Credit Profile Screen, scroll down to the Submitted Credit section to view your certificate. 

For Pharmacists: Pharmacists have up to 30 days to complete the online evaluation and claim credit for participation so that information can be submitted to the CPE Monitor as required. 

Target Audience

The webinar is intended for healthcare providers who treat cancer patients, including oncologists, physicians, disease specialists, registered nurses, nurse practitioners, pharmacists and physician assistants to learn about the recommendations from the recently published SITC Cancer Immunotherapy Guidelines - Renal Cell Carcinoma. 

Webinar Content

• SITC's Cancer Immunotherapy Guidelines on immunotherapy for the treatment of renal cell carcinoma
• New FDA approvals and the role of patient biomarker testing in optimizing treatment selection
• Unique case studies that may require adaptation of cancer immunotherapy regimens
• How best to manage immune-related adverse events

Webinar Faculty

• Michael B. Atkins, MD – Georgetown-Lombardi Comprehensive Cancer Center
• Dena Battle – KCCure
• David McDermott, MD – Beth Israel Deaconess Medical Center
• Brian Rini, MD – Vanderbilt University Medical Center

On-demand Webinar

The recorded webinar video and slides will be available here within 24 hours after the webinar concludes.

(Please note that the on-demand webinars are not available for continuing education credits.) 

Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.

This webinar is supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP, Celgene Corporation and Merck & Co., Inc.